Clinical characteristics and management responses in 85 HIV-infected patients with oral candidiasis

Oral Surgery, Oral Medicine, Oral Pathology, Oral Radiology, and Endodontics

Volumn 82, Issue 4, 1996, Pages 402-407

  Silverman Jr , Sol ^a   Gallo, John W ^b   McKnight, Margaret L ^a   Mayer, Priscilla ^b   DeSanz, Sarah ^a   Tan, Margaret M ^b  

^a University of California ^*  (United States)

^b UNIVERSITY OF CALIFORNIA   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ANTIFUNGAL AGENT; KETOCONAZOLE;

AIDS RELATED COMPLEX; ARTICLE; BACTERIAL COUNT; CD4 LYMPHOCYTE COUNT; DOSE RESPONSE; HUMAN; IMMUNOLOGY; MICROBIOLOGY; SMOKING; THRUSH;

AIDS-RELATED OPPORTUNISTIC INFECTIONS; ANTIFUNGAL AGENTS; CANDIDIASIS, ORAL; CD4 LYMPHOCYTE COUNT; COLONY COUNT, MICROBIAL; DOSE-RESPONSE RELATIONSHIP, DRUG; HUMANS; KETOCONAZOLE; SMOKING;

EID: 0030253204     PISSN: 10792104     EISSN: None     Source Type: Journal    
DOI: 10.1016/S1079-2104(96)80304-0     Document Type: Article

References (38)

1. Phelan JA, Saltzman BR, Friedland GH, Klein RS. Oral findings in patients with acquired immunodeficiency sydrome. Oral Surg Oral Med Oral Pathol 1987;64:50-6.
2. Samaranayake L. Oral mycoses in HIV infection. Oral Surg Oral Med Oral Pathol 1992;2:171-80.
3. Katz M, Greenspan D, Westenhouse J. Progression to AIDS in HIV-infected homosexual and bisexual men with hairy leukoplakia and oral candidiasis. AIDS 1992;6:95-100.
4. Hauman CHJ, Thompson IOC, Theunissen F, Wolfaardt P. Oral carriage of candida in healthy and HIV-seropositive persons. Oral Surg Oral Med Oral Pathol 1993;76:570-2.
5. Duffy RE, Adelson R, Niessen LC, Wescott WB, Watkins K, Rhyne RR. VA Oral HIV surveillance program: understand the disease. J Am Dent Assoc 1992;123:57-62.
6. Melnick SL, Engel D, Truelove E, DeRouen T, Morton T, Schubert M, et al. Oral mucosal lesions: association with the presence of antibodies to the human immunodeficiency virus. Oral Surg Oral Med Oral Pathol 1989;68:37-43.
7. Shiboski CH, Hilton JF, Greenspan D, Westenhouse JL, Derish P, Vranizan K, et al. HIV-related oral manifestations in two cohorts of women in San Francisco. J Acquir Immune Defic Syndr 1994;7:964-71.
8. Lamster IB, Begg MD, Mitchell-Lewis D. Oral manifestations of HIV infection in homosexual men and intraveous drug users. Oral Surg Oral Med Oral Pathol 1994;78:163-74.
9. Sha BE, Benson CA, Pottage JC Jr, Urbanski PA, Daugherty SR, Kessler HA. HIV infection in women: an observational study of clinical characteristics, disease progression, and survival for a cohort of women in Chicago. J Acquir Immune Defic Syndr 1995;8:486-95.
10. Luangjarmekorn L, Silverman S, Gallo J, McKnight M, Migliorati C. Findings in 50 AIDS virus-infected patients with positive oral candida cultures. J Dent Assoc Thai 1990;40:157-65.
11. McCarthy G. Host factors associated with HIV-positive-related oral candidiasis. Oral Surg Oral Med Oral Pathol 1992;2:181-5.
12. Miyasaki SH, Hicks JB, Greenspan D, Polacheck I, MacPhail LA. The identification and tracking of candida albicans isolates from oral lesions in HIV-positive individuals. J Acquir Immune Defic Syndr 1992;5:1039-46.
13. Castro KG, Ward JW, Slutsker L. 1993 revised classification system for HIV infection and expanded surveillance case definition for AIDS among adolescents and adults. MMWR CDC Surveill Summ 1992;41:1-19.
14. Kolokotronis A, Antoniades D, Mandraveli K, Mandraveli K, Doutsos I, Papanayotou P. Immunologic status in patients infected with HIV with oral candidiasis and hairy leukoplakia. Oral Surg Oral Med Oral Pathol 1994;78:41-6.
15. Maden C, Hopkins SG, Lafferty WE. Progression to AIDS or death following diagnosis with a class IV non-AIDS disease: utilization of a surveillance database. J Acquir Immune Defic Syndr 1994;7:972-7.
16. Glick M, Muzyka BC, Lurie D, Salkin LM. Oral manifestations associated with HIV-related disease as markers for immune suppression and AIDS. Oral Surg Oral Med Oral Pathol 1994;77:344-9.
17. Saah AJ, Hoover DR, He Y, Kingsley LA, Phair JP. Factors influencing survival after AIDS: report from the multicenter AIDS cohort study (MACS). J Acquir Immune Defic Syndr 1994;7:287-95.
18. Lynch DP. Oral candidiasis: history, classification, and clinical progression. Oral Surg Oral Med Oral Pathol 1994;78:189-93.
19. Van Meter F, Gallo JW, Garcia-Rojas G, Tan MM, Silverman S Jr. A study of oral candidiasis in HIV-positive patients. J Dent Hyg 1994;68:30-4.
20. Silverman S Jr. Color atlas of oral manifestations of AIDS. Fungal infections. 2nd ed. chap 3. St. Louis: CV Mosby, 1995: 18-38.
21. Como JA, Dismukes WE. Oral azole drugs as systemic antifungal therapy. N Engl J Med 1994;330:263-72.
22. Greenspan D. Treatment of oral candidiasis in HIV infection. Oral Surg Oral Med Oral Pathol 1994;78:211-15.
23. Muzyka BC, Glick M. A review of oral fungal infections and appropriate therapy. J Am Dent Assoc 1995;126:63-72.
24. National Committee for Clinical Laboratory Standards, Villanova, Pa. Reference method for broth dilution antifungal susceptibility testing of yeast: proposed standard. 1992.
25. Dios PD, Alvafez JA, Feijoo IF, Ferreiro MC. Fluconazole response patterns in HIV-infected patients with oropharyngeal candidiasis. Oral Surg Oral Med Oral Pathol 1995; 79:170-4.
26. Newman SL, Flanigan TP, Fisher A, Rinaldi MG, Stein M, Vigilante K. Clinically significant mucosal candidiasis resistant to fluconazole treatment in patients with AIDS. Clin Infect Dis 1994;19:684-6.
27. Rex JH, Rinaldi MG, Pfaller MA. Resistance of candida species to fluconazole. Antimicrob Agents Chemother 1995; 39:1-8.
28. Powderly WG, Finkelstein DM, Feinberg J, Frame P, He W, van der Horst C, et al. A randomized trial comparing fluconazole with clotrimazole troches for the prevention of fungal infections in patients with advanced human immunodeficiency virus infection. N Engl J Med 1995;332:700-5.
29. Flanigan TP. Fluconazole prophylaxis in AIDS: the jury is not yet in on this. AIDS 1995;9:101.
30. Crockett DN, O'Grady JF, Reade PC. Candida species and Candida albicans morphotypes in erythematous candidiasis. Oral Surg Oral Med Oral Pathol 1992;73:559-63.
31. Oppenheim F, Xu T, McMillan F. Histatins, a novel family of histadine rich proteins in human parotid secretion: isolation, characterization, primary structure and fungistatic effects on candida albicans. J Biol Chem 1988;263:7472-7.
32. Challacombe SJ. Immunologic aspects of oral candidiasis. Oral Surg Oral Med Oral Pathol 1994;78:202-10.
33. Epstein JB, Truelove EL, Izutzu KT. Oral candidiasis: pathogenesis and host defense. Rev Infect Dis 1984;6:96-106.
34. Greenberg MS, Dubin G, Stewart JCB, Cumming CG, MacGregor RR, Friedman HM. Relationship of oral disease to the presence of cytomegalovims DNA in the saliva of AIDS patients. Oral Surg Oral Med Oral Pathol 1995;79:175-9.
35. Epstein JB, Burchell JL, Emerton S, Le ND, Silverman S Jr. A clinical trial of bethanechol in patients with xerostomia after radiation therapy. Oral Surg Oral Med Oral Pathol 1994; 77:610-4.
36. Odds FC. Candida species and virulence. ASM News 1994; 60:313-8.
37. Cannon RD, Holmes AR, Mason AB, Monk BC. Oral candida: Clearance, colonization, or candidiasis? J Dent Res 1995;75:1152-61.
38. Navazesh M, Wood GJ, Brightman V. Relationship between salivary flow rates and candida albicans counts. Oral Surg Oral Med Oral Pathol 1995;80:284-8.